We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

39 hedge funds and large institutions have $157M invested in Kindred Biosciences, Inc. in 2014 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

238% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 8

95% more funds holding

Funds holding: 20 → 39 (+19)

71% more capital invested

Capital invested by funds: $91.5M → $157M (+$65.3M)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
39
Holders Change
+19
Holders Change %
+95%
% of All Funds
1.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
5
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.04M
2
BFA
BlackRock Fund Advisors
California
+$4.5M
3
PWAM
Park West Asset Management
California
+$4.01M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.88M
5
SCM
Sarissa Capital Management
Connecticut
+$1.94M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$5.24M
2
Franklin Resources
Franklin Resources
California
-$3.37M
3
BG
Baupost Group
Massachusetts
-$2.6M
4
DM
Deerfield Management
New York
-$2.51M
5
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
-$1.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$260K +$268K +14,050 New
PAM
27
Panagora Asset Management
Massachusetts
$244K +$251K +13,150 New
PP
28
PDT Partners
New York
$217K +$223K +11,694 New
TC
29
TFS Capital
Pennsylvania
$204K +$210K +10,994 New
TSW
30
Thompson Siegel & Walmsley
Virginia
$176K +$181K +9,500 New
Citadel Advisors
31
Citadel Advisors
Florida
$155K +$160K +8,385 New
BA
32
BlackRock Advisors
Delaware
$96K +$98.5K +5,167 New
SO
33
STRS Ohio
Ohio
$59K +$61K +3,200 New
NFA
34
Nationwide Fund Advisors
Ohio
$49K +$50.5K +2,648 New
Deutsche Bank
35
Deutsche Bank
Germany
$17K +$18.3K +960 New
TRCT
36
Tower Research Capital (TRC)
New York
$9K -$84.2K -4,416 -90%
BlackRock
37
BlackRock
New York
$5K +$4.63K +243 New
Barclays
38
Barclays
United Kingdom
$4K +$4.48K +235 New
Citigroup
39
Citigroup
New York
$1K -$744 -39 -46%
Franklin Resources
40
Franklin Resources
California
– -$3.37M -302,800 Closed
DM
41
Deerfield Management
New York
– -$2.51M -225,000 Closed
FCM
42
Farallon Capital Management
California
– -$918K -82,445 Closed
BI
43
BVF Inc
California
– -$577K -51,788 Closed
HVC
44
Healthcare Value Capital
New Jersey
– -$559K -50,000 Closed
HHC
45
Hutchin Hill Capital
New York
– -$131K -11,719 Closed
CCA
46
Catalyst Capital Advisors
New York
– -$111K -10,000 Closed
U
47
UBS
Switzerland
– -$14K -1,291 Closed
1
2

KIN Hedge Fund Activity: Q1 2014 in Review

39 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q1 2014, worth a combined $157M — up 71% from $91.5M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new KIN positions and 8 closed out — a net gain of 19 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $5.04M. The largest seller was Adage Capital Partners, cutting an estimated $5.24M.

  • 39 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q1 2014, up from 20 in Q4 2013.
  • Funds reported $157M of Kindred Biosciences, Inc. stock for Q1 2014, up 71% quarter-over-quarter.
  • 27 funds opened new Kindred Biosciences, Inc. positions in Q1 2014 and 8 closed out, a net change of +19 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q1 2014 was Fidelity Investments, an estimated $5.04M added.
  • The largest Kindred Biosciences, Inc. seller in Q1 2014 was Adage Capital Partners, an estimated $5.24M sold.

Based on aggregated 13F filings for Q1 2014.